by Co-Diagnostics | Aug 28, 2019 | News Release
Salt Lake City, Utah – August 28, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be featured as a presenting company at the... by Co-Diagnostics | Aug 21, 2019 | News Release
Event to include demos and training for distributors and end-users of Company’s products Salt Lake City, Utah – August 21, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of... by Co-Diagnostics | Aug 14, 2019 | News Release
Q2 revenue reflects increase over Q1, as US sales of mosquito abatement products and AgBio primer design services gain momentum Salt Lake City, Utah – August 14, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented... by Co-Diagnostics | Aug 1, 2019 | News Release
Company’s booth will promote infectious disease products and technology applications for NGS, liquid biopsy, and SNP differentiation Salt Lake City, Utah – August 1, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented... 